| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |